Skip to main content
Log in

Rivoceranib

Various toxicities

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Wang C, et al. Neoadjuvant PD-1 Inhibitor Plus Apatinib and Chemotherapy Versus Apatinib Plus Chemotherapy in Treating Patients With Locally Advanced Gastric Cancer: A Prospective, Cohort Study. Journal of Gastric Cancer 23: 328-339, No. 2, Apr 2023. Available from: URL: 10.5230/jgc.2023.23.e17

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rivoceranib. Reactions Weekly 2007, 303 (2024). https://doi.org/10.1007/s40278-024-58863-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-58863-6

Navigation